Related references
Note: Only part of the references are listed.Dasatinib Inhibits the Development of Metastases in a Mouse Model of Pancreatic Ductal Adenocarcinoma
Jennifer P. Morton et al.
GASTROENTEROLOGY (2010)
Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis
T. Koreckij et al.
BRITISH JOURNAL OF CANCER (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Specific Cross-talk between Epidermal Growth Factor Receptor and Integrin αvβ5 Promotes Carcinoma Cell Invasion and Metastasis
Jill M. Ricono et al.
CANCER RESEARCH (2009)
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model
Roberta Vitali et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
An integrin αvβ3-c-Src oncogenic unit promotes anchorage-independence and tumor progression
Jay S. Desgrosellier et al.
NATURE MEDICINE (2009)
Estrogens and genomic instability in human breast cancer cells - involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals
Alena Kabil et al.
CARCINOGENESIS (2008)
The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia
R. M. Thomas et al.
GUT (2008)
Src kinase induces tumor formation in the c-SRC C57BL/6 mouse
Christina Leah B. Kline et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Pancreatic ductal adenocarcinoma: Cellular origin, signaling pathways and stroma contribution
Inmaculada Hernandez-Munoz et al.
PANCREATOLOGY (2008)
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Eric A. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras
Katrina Podsypanina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression
Ryan M. Thomas et al.
CANCER RESEARCH (2007)
KrasG12D and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas
Kamel Izeradjene et al.
CANCER CELL (2007)
Src signaling regulates completion of abscission in cytokinesis through ERK/MAPK activation at the midbody
Kousuke Kasahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-β signaling in cooperation with active Kras expression
Hideaki Ijichi et al.
GENES & DEVELOPMENT (2006)
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer
Nabeel Bardeesy et al.
GENES & DEVELOPMENT (2006)
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy
Nadia Rucci et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Genetics and biology of pancreatic ductal adenocarcinoma
Aram F. Hezel et al.
GENES & DEVELOPMENT (2006)
Inhibition of Src expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model
JG Trevino et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Csk-deficient boundary cells are eliminated from normal Drosophila epithelia by exclusion, migration, and apoptosis
M Vidal et al.
DEVELOPMENTAL CELL (2006)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
c-Src and cooperating partners in human cancer
R Ishizawar et al.
CANCER CELL (2004)
Development of transgenic mice that inducibly express an active form of c-src in the epidermis
T Matsumoto et al.
MOLECULAR CARCINOGENESIS (2004)
An illustrated consensus on the classification of pancreatic Intraepithelial neoplasia and intraductal papillary mucinous neoplasms
RH Hruban et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Discovery of N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays
LJ Lombardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Inhibition of Src tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice
MV Yezhelyev et al.
CLINICAL CANCER RESEARCH (2004)
The interplay between Src family kinases and receptor tyrosine kinases
PA Bromann et al.
ONCOGENE (2004)
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma
AJ Aguirre et al.
GENES & DEVELOPMENT (2003)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Magnetic resonance imaging of the pancreas and pancreatic tumors in a mouse orthotopic model of human cancer
J Grimm et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
The in vitro micronucleus technique
M Fenech
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2000)
Role of Src expression and activation in human cancer
RB Irby et al.
ONCOGENE (2000)
No requirement for Src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen
MA Broome et al.
ONCOGENE (2000)
Share Paper
